
Lam Research (LRCX) is positioned as a more attractive investment than ASML in the semiconductor equipment sector due to its strong near-term momentum and financial execution. LRCX's AI-focused tools drove over $1 billion in 2024 sales, with 2025 shipments projected to triple to over $3 billion, while its non-GAAP operating margin improved to 32.8% in Q3. Despite ASML's market leadership in EUV lithography and robust Q1 2025 revenue growth of 46%, LRCX's lower valuation and superior year-to-date stock performance (+33.9% vs. ASML's +14.1%) make it a more compelling buy, especially given ASML's exposure to China export restrictions.
Both ASML Holding and Lam Research are critical, complementary suppliers in the semiconductor equipment industry, poised to benefit from secular growth in AI. ASML maintains a technological monopoly with its EUV lithography machines, reflected in strong Q1 2025 results showing 46% revenue growth and a 93% jump in EPS. However, its outlook is tempered by significant geopolitical risk, with 41% of its 2024 shipments directed to China, a market now subject to U.S.-led export restrictions. In contrast, Lam Research demonstrates superior near-term execution and momentum. Its AI-focused tool shipments are projected to triple from over $1 billion in 2024 to more than $3 billion in 2025. This operational strength is translating into financial outperformance, with LRCX reporting a 210 basis point sequential expansion in its non-GAAP operating margin to 32.8% in Q3, with further improvements guided for Q4. This momentum is reflected in its stock performance, up 33.9% year-to-date versus ASML's 14.1%, and a more favorable valuation, trading at a 24.17x forward earnings multiple compared to ASML's 27.34x.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.65
Ticker Sentiment